key: cord-0718787-9swigflq authors: Alam, Rahat; Imon, Raihan Rahman; Kabir Talukder, Md. Enamul; Akhter, Shahina; Hossain, Md. Alam; Ahammad, Foysal; Rahman, Md. Mashiar title: GC-MS analysis of phytoconstituents from Ruellia prostrata and Senna tora and identification of potential anti-viral activity against SARS-CoV-2 date: 2021-12-17 journal: RSC advances DOI: 10.1039/d1ra06842c sha: 33fb56d4437ba6efce4b9cb82d1653fc0133f504 doc_id: 718787 cord_uid: 9swigflq SARS-CoV-2 is an etiologic agent responsible for the coronavirus disease 2019 (COVID-19) pandemic. The virus has rapidly extended globally and taken millions of lives due to the unavailability of therapeutics candidates against the virus. Till now, no specific drug candidates have been developed that can prevent or treat infections caused by the pathogen. The main protease (M(pro)) of the SARS-CoV-2 plays a pivotal role in mediating viral replication and mechanistically inhibition of the protein can hinder the replication and infection process of the virus. Therefore, the study aimed to identify the natural bioactive compounds against the virus that can block the activity of the M(pro) and subsequently block viral infections. Initially, a total of 96 phytochemicals from Ruellia prostrata Poir. and Senna tora (L.) Roxb. plants were identified through the gas chromatography-mass spectrometry (GC-MS) analytical method. Subsequently, the compounds were screened through molecular docking, absorption, distribution, metabolism, excretion (ADME), toxicity (T), and molecular dynamics (MD) simulation approach. The molecular docking method initially identified four molecules having a PubChem CID: 70825, CID: 25247358, CID: 54685836 and, CID: 1983 with a binding affinity ranging between −6.067 to −6.53 kcal mol(−1) to the active site of the target protein. All the selected compounds exhibit good pharmacokinetics and toxicity properties. Finally, the four compounds were further evaluated based on the MD simulation methods that confirmed the binding stability of the compounds to the targeted protein. The computational approaches identified the best four compounds CID: 70825, CID: 25247358, CID: 54685836 and, CID: 1983 that can be developed as a treatment option of SARS-CoV-2 disease-related complications. Although, experimental validation is suggested for further evaluation of the work. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been recognized as the etiologic agent of the ailment termed coronavirus disease 2019 (COVID-19). 1 The virus created a life-threatening circumstance to the worldwide public community with surge mortality and sickness. [2] [3] [4] The etiologic agent of COVID-19 was rst identied in patients with pneumonia during the outbreak of this virus infection in Wuhan, China on 29 December 2019, and is still enduring a radical challenge to global public health security. 5, 6 Patients infected with the pathogen experience common cold to more rare and serious respiratory diseases that can be led to death due to the lack of appropriate treatment options. 7 To date, more than 263.1 million (December 01, 2021, 06:57 GMT) conrmed COVID-19 cases were recorded with more than 5.23 million deaths in 222 countries and territories around the world (https://www.worldometers.info/coronavirus). Nevertheless, available therapeutics have not been developed and suggesting the emergency of developing specic drug candidates against the virus. 8 The SARS-CoV-2 is an enveloped single-stranded RNA betacoronavirus that contain a genome ranging from 26 to 32 kb in length. 9 The virus belongs to the Coronaviridae family that has sequence identity 82% and >90% with SARS-CoV, and Middle East respiratory syndrome coronavirus (MERS-CoV), respectively. 10 Infections of this virus may cause lower respiratory tract disease, gastrointestinal, liver, and central nervous system damage in humans and animals, but SARS-CoV-2 infection is much more severe than the other two coronaviruses. 11 Although the virus uses the same receptor angiotensinconverting enzyme 2 (ACE2) of SARS-CoV to enter into the host, SARS-CoV-2 can be transmitted from human to human more frequently. 12, 13 Initially, the structural spike (S) glycoproteins known as the main antigen component in all proteins of the SARS-CoV-2 plays an important role in the host receptor recognition and fusion mediate entry process (Fig. 1) . The S protein of the virus includes two subunits known as S1 and S2. 14 The S1 subunit recognizes and attaches to the host receptor ACE2, and another cellular serine protease is known as TM protease serine 2 (TMPRSS2) help in S protein priming by cleavage at the S1/S2 and the S2 0 site and promotes fusion mediate entry into host the cell. 15 The fusion mediates entry releases the viral polycistronic RNA in the cytoplasm and is translated into replicase polyprotein pp1a or pp1ab. 16 The polyprotein is latterly cleaved by the main protease M pro (also called 3CL pro ) and papain-like protease (PL pro ) that produce 16 non-structural proteins. 15, 17, 18 Later, the proteins of the virus make a replicase-transcriptase complex (RTC) also known as a multiprotein complex, and further utilized for the synthesis of the full-length genome of the virus. 19 The multiprotein complex also consists of RNA-dependent RNA polymerase (RdRp) plays an important role in the transcription of the viral genomic RNA. 20 The structural and nonstructural proteins undergo the translation process and assemble into the lumen of the endoplasmic reticulum (ER). Finally, the assemble immature viruses are mature from the Golgi intermediate compartment and subsequently release into the cells. 21 As, the virus M pro plays an important role in virus translation and replication, therefore blocking the protein will be able to hinder the replication process of the virus. 22 Medicinal plants and isolated phytochemicals encompass a diverse chemical space are widely used in the treatment of various viral diseases and drug discovery. 23 Natural bioactive compounds isolated from different medicinal plants has gained the focus of modern world healthcare researchers due to optimum side effect and better synthesis accessibility. 24 Over the last few decades, phytochemicals-dependent drug discovery has been accelerated because of their antiviral, proinammatory, and antioxidant activities. 25 The natural compounds isolated from different medicinal plants interact with diverse host targets and can regulate the signaling mechanisms of the host. The phytochemicals also help in reducing pro-inammatory, 26 as well as immune-boosting 27 such as Tumor necrosis factor-alpha (TNF-a), Interleukin (IL-1, 6, 8, 1b), Nuclear factor-kappa B (NF-kB), and Reactive oxygen species (ROS) 28 and help to minimize respiratory disorders. 29 Since infection with the SARS-CoV-2, can motive critical lung damage and breathing problems, the phytochemicals or secondary metabolites of the plants can help to lessen the severity of those pulmonary (airways, lungs, and blood vessels) systems along with antiviral (especially anti-CoVs) effects. Previously different medicinal plants include Allium sativum, Camellia sinensis, Zingiber officinale, Nigella sativa, Echinacea spp., Hypericum perforatum, and Glycyrrhiza glabra, Scutellaria baicalensis, and the secondary metabolites of the plant show anti-viral properties against different coronavirus. 30, 31 The natural bioactive compounds originated from different medicinal plants show potential benets for COVID-19 prevention. Therefore, plant-based potential bioactive compounds can be utilized as preventive and therapeutic option against SARS-CoV-2. R. prostrata Poir is an annual perennial herb that grows up to 25-40 cm belongs to the Acanthaceae family and is native to the Central African Republic to Eritrea and South Africa, Arabian Peninsula, and the Indian Subcontinent include Bangladesh. 32 The plant extract has been used as herbal medicine for treating humans due to its analgesic, antitussive, hypotensive and anti-inammatory effects. [32] [33] [34] [35] [36] [37] [38] [39] Where, S. tora (L.) Roxb is another herbaceous annual fetid medicinal herb that grows to a height of 1 m in the wastelands and roadsides of tropical Asia includes Bangladesh. 38 The extract of the plant was lethal for chloroquine-resistant and chloroquine-sensitive Plasmodium falciparum and frequently used for medicinal purposes, including as components of laxatives, anti-inammatory agents, cardioprotective, antibacterial, antifungal, antiarthritic, anticancer, and hepatoprotection. [40] [41] [42] [43] [44] [45] The previous study found that the extract of this medicinal plant is assumed to have the capacity to modulate the immune response, but the activity of the plant against SARS-CoV-2 remains unknown. Therefore, the study examined the antiviral properties of the two plants against SARS-CoV-2. Computer-aided drug design (CADD) has become a popular method for over three decades that are being utilized in the screening, development, and design of therapeutically important molecular candidates. 46 These methods are a combination of different approaches includes molecular docking, ADME ("absorption, distribution, metabolism, and excretion"), toxicity, and molecular dynamics (MD) simulation that help to optimize and screen compounds more effectively. Nowadays, molecular docking is another popular method that helps to determine the interaction between a target protein and small molecules candidates. 47 The methods can initially identify the potential molecules that can be further utilized for drug design, where MD simulation can conrm the stability of the desired molecules to the target protein. The ADME indicates pharmacokinetics and pharmacology properties that are vital steps in the drug design process and allow us to understand the safety and efficacy of a small molecular candidate as a drug. Toxicity analysis is another step of the drug design process that can also analysis through computational methods and able to determine an adverse biological effect chemical substance or a small molecular candidate. Previously many small molecular candidates have been identied through the CADD approaches that have passed clinical trials and become novel therapeutics in the treatment of different viral diseases. 48, 49 Therefore, the study aimed to identify bioactive natural compounds from R. prostrata aerial parts and S. tora leaves by Gas chromatography-mass spectrometry (GC-MS) and computational approaches that can be utilized as a treatment option for COVID-19. The aerial parts of R. prostrata Poir. were collected in March 2019 from Churamonkathi, Jashore, Bangladesh. The leaves of Senna tora (L.) Roxb. were collected in July 2019 from Newmarket, Noapara, and Jashore, Bangladesh. Botanical identication and authentication were done by the taxonomist Dr Sardar Nasiruddin, Chief Scientic Officer, National Herbarium, Dhaka, Bangladesh. The deposited voucher number was DACB 65141 for R. prostrata Poir and DACB 65146 for S. tora (L.) Roxb. Individual plant parts were washed under tap water and rewashed under distilled water. Initially, plant parts were air-dried in the shade at room temperature (25 C) and then crushed into ne powder by using a mechanical grinder and passing through a 50-mesh size. The ne powder was stored in an air-tight container. The plant product extraction was conducted through the method dened previously by Rahman et al., with some minor modications. 50 Briey, ve hundred grams of powdered plant material from each plant was distributed separately into a ve-1000 mL conical ask. Each conical ask was lled with 400 mL of ethyl acetate and shaken at 250 rpm for 72 h at 37 C. The mixture was ltered rst by cleaned cotton gauze and then by Whatman no. 1 lter paper. To evaporate the solvent, the ltrates were concentrated under a vacuum on a rotary evaporator (Stuart, UK) at room temperature to obtain concentrated extracts of R. prostrata (25.55 g dry weight, 5.11% w/w) and S. tora (25.55 g dry weight, 6.03% w/w). Each extract was subjected to GC-MS analysis to determine the compounds. (1) . The S protein of the virus recognizes the host receptor ACE2 and binds with the protein. The S protein cleavage at the S1/S2 and the S2 0 site with the help of serine protease TMPRSS2, (2) . Activation of the S2 subunits of the S protein, (3) . Allows fusion of viral and cellular membranes resulting entry of the virus, (4) . Release of the viral genome into the cytoplasm of the host cell, (5) . Translation of viral polymerase and formation of replicase polyprotein pp1a and pp1ab, (6) . Polyprotein cleavage by the main protease M pro (also called 3CL pro ) and papain-like protease (PL pro ) and production of replicase-transcriptase complex that translated into the transcript and assemble into the lumen of the endoplasmic reticulum (ER), (7) . Immature virus maturation by the help of Golgi intermediate compartment, (8) . Release of the virus. The phytochemicals of R. prostrata and S. tora were analyzed by Gas Chromatography-Mass Spectroscopy (Shimadzu triple-quad GCMS-TQ8040) with an Rtx-5MS capillary column (30 m  0.25 mm id, lm thickness of 0.25 mm). 51 Initially, 1 mL of the sample was injected in splitless mode into the injection port of the GC column at a constant ow rate of 1 mL per minute. The injection temperature was kept at 250 C and helium gas was used as a carrier during the process. The initial column oven temperature was set at 50 C for 1 minute, then 200 C for 2 minutes, and nally 300 C for 7 minutes, by using a temperature control system, where the total run time was set for 40 min. The following detector parameters were used for GC-MS analyses: interface temperature of 250 C, ion source temperature of 230 C, mass spectrometry with Q3 scan, m/z 50-600 scanning range, scan speed mode 2000, and scan time of 0.3 s per scan. The peak area denotes the relative percentage of extracted constituents. Aer comparing the spectral congurations obtained with those of the available mass spectral National Institute of Standards and Technology (NIST) library was used to identify the compounds. The 3D crystal structure of the SARS-CoV-2 main protease (M pro ) was retrieved from the RCSB Protein Data Bank having a PDB ID: 6LU7. The atomic and molecular structure of the crystal was resolved by the X-ray diffraction method that has a resolution value of 2.16Å. 52 Initially, the protein structure was prepared by using the Protein preparation wizard available at Maestro v11.4. 53 The default parameter of preparation wizard has been utilized to prepare the protein and the bond orders of the protein have been assigned, hydrogens were added, missing side chains were added, and subsequently, the water of the protein was removed. The PubChem database (https:// pubchem.ncbi.nlm.nih.gov/) was used to retrieve the 3D structure of bioactive compounds and further processed by the LigPrep option of maestro v11.4. Finally, the protein and chemical structures were optimized by using the OPLS3e force eld. 54 Protein-ligand binding score analysis by molecular docking Molecular docking studies can reveal the binding interactions between specic proteins and desire ligands. Natural compounds identied through GS-MS have been docked with the desired macromolecules through the Glide package of the Schrödinger Suite. 55 The docking process utilized OPLS3e as a force eld in standard precision mode. 54 The native inhibitor (N3) in a complex with the desired protein has been analyzed and the binding position was chosen for receptor grid generation. The binding site residues-based receptor grid identied a box range X ¼ À13.334, Y ¼ 14.058, Z ¼ 69.482. From this, target protein and ligand binding energy were obtained. Ligand binding residues and different kinds of chemical bonds were visualized by the Maestro viewer. Pharmacokinetics is the mathematical observation of the ADME properties related to the intensity and time course of a drug. The computational drug design and development process relay on the early-stage assessment of pharmacokinetics properties that help to optimize a molecular candidate to become an effective drug. 56 Therefore, the pharmacokinetic properties of the selected compounds were identied by using a freely accessible web tool known as Swiss-ADME (http://www.swissadme.ch/index.php) server. 57 The server helps to observe and predict various pharmacokinetic and pharmacodynamic properties of the selected compounds. endpoints like mutagenicity, carcinogenicity, and other features, and these endpoints can be measured both quantitatively and qualitatively. 59 The selected compound's toxicity (mutagenicity, carcinogenicity, acute toxicity) was accessed through the ProTox-II (https://tox-new.charite.de/protox_II/) server. 60 Protein-ligand stability analysis by molecular dynamics simulation Molecular dynamics (MD) simulation was carried out to observe the structural stability of the protein-ligand complex in a specic physiological environment. A 150 ns MD simulation was carried out by using the Desmond package available at Schrödinger suit. 61 Initially, the protein-ligand complexes structure was generated from molecular docking studies and the complex structure was pre-processed by using the protein preparation wizard. 18 For each complex simple point-charge (SPC) water model was used to solve the system and an orthorhombic periodic boundary box shape with distance (10  10  10Å 3 ) has been assigned to maintain a specic volume of the systems. Na + and Cl À ions were chosen and placed randomly in the solvated system to maintain a salt concentration of 0.15 M. The system was minimized and relaxed by using the OPLS3e force eld. 62 Finally, the constant pressure-constant temperature (NPT) ensemble was performed at 300.0 K temperature and 1.01325 bar pressure. 63 The system for each complex was relaxed initially followed by 150 picoseconds recording intervals with an energy of 1.2 was used to nal production run. 64 Furthermore, RMSD, RMSF, rGyr, and SASA values were calculated to evaluate the stability and dynamic properties of these complexes. 65 The entire molecular docking and molecular dynamics simulations were executed in the Linux (Ubuntu-20.04.1 LTS) environment with an Intel Core i7-10700K processor CPU, 3200 MHz DDR4 RAM, and RTX 3080 DDR6 8704 CUDA core GPU. The GC-MS analysis of R. prostrata and S. tora plant identied 43 and 53 peaks, respectively. Observation of retention time (RT), peak area (percent), and molecular formula identied the presence of unique compounds for each peak. During the 50 min retention time, the ethyl acetate extracts of R. prostrata isolated a total of 43 compounds shown in Fig. 2A and listed in Table 1 , where S. tora determined 53 compounds shown in Fig. 2B and listed in Tables 1 and S1. † Most of the compounds were eluted between 4.0-39.0 min analysis time and a total of 96 compounds were identied in this study. A molecular docking study was performed to understand molecular interactions and binding affinity between the target protein and phytochemicals. The M pro of SARS-CoV-2 (PDB ID: 6LU7) and the phytochemicals were docked to identify the binding score between protein and the compounds and the binding score has listed in Tables S2 and S3. † Based on the docking score the best two compounds (CID: 25247358, CID: 70825) from R. prostrata and two compounds (CID: 54685836, CID: 1983) from S. tora have been selected, where the cut-off energy value was À6.00 kcal mol À1 (Fig. 3) . Interestingly, compound CID: 70825 was found for both plants, which has a binding score >À6.0 kcal mol À1 . As the compounds were the same for both plants that showed the highest score and instead of the compound CID: 70 825 the compound CID: 1983 has been taken for further evaluation. The nal four compounds (CID: 25247358, CID: 70825, CID: 54685836, CID: 1983) were considered for further evaluation in this study. The best docking score containing selected four compounds has been retrieved for further analysis and molecular interactions have been visualized through the Maestro module of the schrödinger suite shown in Fig. 4 . Different types of non-bonded interactions between receptors and ligands, like hydrogen bonds, electrostatic bonds, and hydrophobic bonds, have been identi-ed. The compounds of R. prostrata namely 4,5-dimethoxy-2-[(4methylphenyl) carbonyl]benzonitrile (CID: 25247358), 4,5dimethoxy-2-[(4-methylphenyl)carbonyl]benzonitrile (CID: 70825) showed an energy score À6.53 kcal mol À1 and À6.427 kcal mol À1 , respectively ( Table 2) . Another plant S. tora compounds namely L- ascorbic acid, 5,6-O-ethylboranediyl-(CID: 54685836), and acetaminophen (CID: 1983) showed À6.222 kcal mol À1 and, À6.067 kcal mol À1 binding energies respectively. All 4 compounds showed interaction with a different amino acid that is illustrated and represented in Fig. 4 and listed in Table 2 . The cocrystal N3 inhibitor has a polar bond with THR24, THR25, Table 2 and shown in Fig. S1 . † The THR25, HIS41, HIS163, HIS164, HIE172, PHE140, LEU141, GLY143, CYS145, MET165 residues are common interacting residues among 4 ligands and N3 inhibitors. Pharmacokinetics properties that comprise ADME properties are inuenced by the route of administration and the functioning of body organs of a drug that depends on patient-related factors as well as on the drug's chemical properties. These properties can indicate that drugs will not fail during clinical trials for reasons that could have been determined and skipped. Therefore, the selected compounds Pharmacokinetics properties have been evaluated. The compounds (CID: 25247358, CID: 70825, CID: 54685836, CID: 1983) have been evaluated based on their physicochemical, lipophilicity, water-solubility, gastrointestinal absorption, drug-likeness (Lipinski's rule of ve), and synthesis accessibility and listed in Table 3 . All the compounds selected in the study show good pharmacokinetics properties indicate that drugs have low chances to fail during clinical trials. Toxicity can be dened as the degree to which a chemical compound can harm a living organism. The toxicity can damage the formation of essential enzymes in an organism through a single or short-term exposure and can lead to the failure of a major organ. Sometimes the compounds designed as drug candidates can be toxin and harmful for another organ that can cause organ toxicity, toxicity immunotoxicity, mutagenicity, and cytotoxicity for human or animal body. Therefore, the toxicity of the selected four compounds has also been accessed in this study. All the selected four compounds CID: 25247358, CID: 70825, CID: 54685836, CID: 1983 good toxicity properties, which were in the toxicity class of V, IV, V, IV, respectively, and listed in Table 4 . Protein-ligand complex stability and conformational exibility by MD simulation MD simulation can be applied in computer-aided drug discovery to understand the protein-ligand complex's stability and intermolecular interaction in reference time. It can also determine the conformational change of the complex system in an articial environment. Therefore, to understand conformational changes of the protein in complex with selected ligand a 150 ns MD simulation was performed in this study. Initially, the last snapshots were extracted from the respective 150 ns MD trajectories and analyzed for intermolecular behavior observation. The MD simulation result was analyzed based on root-mean-square deviation (RMSD), root means square uctuation (RMSF), the radius of gyration (R g ), and Solvent Accessible Surface Area (SASA). Protein-ligand interaction mapping, ligand-protein contacts, and intramolecular hydrogen bond of protein-ligand during simulation time. The root means square deviation (RMSD) value is used to calculate the mean variation in dislocation of selected atoms for a particular time compared to a reference time. The average change in RMSD of the protein-ligand complex with a range between 1-3Å is completely acceptable. If the RMSD value is larger than 1-3Å it means, there is a vast conformational change in the protein structure. Therefore, to evaluate the conformation change of the desired protein in the complex of the selected compound includes CID: 70825, CID: 25247358, CID: 54685836, and CID: 1983 a 150 ns MD simulation was performed and the correspondence RMSD value was observed. In the case of the compound CID: 70825 the average RMSD value was in a range between 2.1Å to 2.3Å. The uctuation was a bit high at a range between 85 to 90 ns simulation time and the least of the time the compound shows good stability compared to the M pro apoprotein shown in Fig. 5 . The average RMSD value change from the M pro Apo to another three compounds CID: 25247358, CID: 54685836, and CID: 1983 maintenance an average range of 1-2.5Å. The value change for the compound shows very optimum uctuation, which was lower than the desired range indicated the conformational stability of the protein-ligands complex structure shown in Fig. 5 . The Root Mean Square Fluctuation (RMSF) can help to characterize and determine the local changes within the protein chain during the interaction of compounds to the specic residues. Therefore, the RMSF value of the compounds CID: 25247358, CID: 70825, CID: 54685836, CID: 1983 in complex with the M pro were calculated to observe the change in protein structural exibility during the attachment of selected compounds to a specic residual position and shown in Fig. 6 . In Fig. 6 , all the selected compounds show a peak area of the protein at GLY711, ASP153, GLY193, and ASN277 residual positions that uctuate the most during the simulation. The RMSF found minimal between 5 to 295 AA residue of the most Table 4 Toxicity properties like organ toxicity, toxicity endpoints include immunotoxicity, mutagenicity, cytotoxicity, oral rat LD 50 value of selected 4 compounds Endpoint Target CID: 25247358 CID: 70825 CID: 54685836 CID: 1983 Organ toxicity Hepatotoxicity Inactive Inactive Inactive Inactive Toxicity endpoints Carcinogenicity Inactive Inactive Inactive Inactive Immunotoxicity Low Low Low Low Mutagenicity Inactive Inactive Inactive Inactive Cytotoxicity Inactive Inactive Inactive Inactive LD rigid secondary structure elements includes alpha-helices and beta-strands. Compare to native structure elements (apo) to the complex structure the uctuation of the residues is very low indicating the rigidity of the protein structure. Most of the uctuation observe at the initial and last portion of the protein due to the presence of the N-and C-terminal domain. Therefore, it can be said that the displacement of a particular atom has a low uctuation probability in a real-life environment for all the selected four compounds. Hydrogen bonds play a critical role in drug binding to the binding site of the desired protein. The number of hydrogen bonds can help to characterize a drug, that has a strong inuence on drug specicity, metabolization, and adsorption. Therefore, the number of hydrogen bonds of the selected compounds CID: 25247358, CID: 70825, CID: 54685836, CID: 1983 in complex with the M pro was computed for systems by investigating congurations every 150 ps represented in Fig. 7 . Hydrogen bond numbers were calculated from initial to nal times during the 150 ns simulation run to observe each hydrogen bond. All the compounds formed several hydrogen bonds ranging between 250 to 290 occur simultaneously until 150 ns simulation time. Therefore, all the compounds will increase the strength and stability of the ligands-receptor interaction substantially. The radius of gyration (R g ) can be dened as the distribution of atoms of a protein-ligand complex system around its axis. The computation of R g is one of the most important markers for forecasting a macromolecule's structural activity and indicates the changes in complex compactness. Therefore, the stability of CID: 70825, CID: 25247358, CID: 54685836, CID: 1983 in complex with the desired protein were also analyzed in terms of R g over 150 ns simulation time shown in Fig. 8 . The average R g was found to be 2.9, 3.6, 3.01, and 2.6 for the compounds CID: 70825, CID: 25247358, CID: 54685836, CID: 1983, respectively indicating the active site of the protein does not induce major conformational changes aer binding the selected compounds. The structure and function of biological macromolecules are inuenced by solvent-accessible surface area (SASA). In most cases, amino acid residues on a protein's surface operate as active sites and/or interact with other molecules and ligands that help to understand the solvent-like behavior (hydrophilic or hydrophobic) of a molecule as well as protein-ligand complexes. Therefore, the SASA value of the protein in complex with the compounds CID: 70825, CID: 25247358, CID: 54685836, CID: 1983 were calculated and presented in Fig. 9 . The SASA value identied for the complex system was an average between 75 to 400Å 2 indicating the high level of exposure of an amino acid residue to the selected compound in the complex systems. The complex structure of a protein with the selected ligands and their intermolecular interactions has been evaluated for 150 ns simulation time via the simulation interactions diagram (SID). Depending on some parameters, including hydrogen bond, non-covalent bond (hydrophobic bond), ionic bond, and water bridge bond, the contact between protein and the selected compounds CID: 70825, CID: 25247358, CID: 54685836, CID: 1983 have been analyzed and represented in Fig. 10 . During the 150 ns simulation time, all compounds were found to form different multiple interactions through hydrogen, hydrophobic, ionic, and water bridge bonding and maintenance until the end of the simulation and helped to make a stable binding with the desired protein. SARS-CoV-2 appoints a devastating situation all over the world and various medication strategies are trying to be developed. 66, 67 For thousands of years, natural products and their derivatives isolated from various sources have been demonstrated to be effective therapeutic agents, and thus play an important role in treating diverse infectious diseases. 68 The chemical structure and extensive biological activities of these compounds vary comprehensively. That's why natural compounds incessantly offer inspiration for innovations in drug discovery and medical sciences. 69 Recently, researchers from different parts of the world have been working extensively to nd certain potential lead compounds from medicinal plants that are active against several enzymes and other proteins responsible for the SARS-CoV-2 replication and transcription. 70, 71 Till now, no specic drug candidates of the virus have been determined. The plant R. prostrata previously showed anti-inammatory and antioxidant properties, 34 and the leaf extract of the S. tora plant is reported to have antiviral, antibacterial, antifungal, and anti-arthritic activity. 40 But the activity of the plant as a medication option of SARS-CoV-2 remains unknown. Therefore, the study aims to identify potential natural M pro inhibitors through computational approaches to overcome the current devastating situation that originated from SARS-CoV-2. In this study, we have identied potential drug candidates against SARS-CoV-2 by targeting the M pro of the virus. Initially, the compounds of R. prostrata and S. tora plant were identied through the GS-MS analysis approach. Subsequently, the iden-tied compounds were screened through the molecular docking process that primarily selected four compounds CID: 70825, CID: 25247358, CID: 54685836, CID: 1983 having a lower binding affinity. The compounds tted with the active pockets of the SARS-CoV-2 M pro that interacted with HIE41 and Cys145 residues. Interestingly, the HIE41 and Cys145 residues belong to the catalytic dyads of the SARS-CoV-2 M pro . 72 The RO5 demonstrated the drug-like properties of the selected compounds. 73, 74 The pharmacokinetics include the ADME properties of all the selected four compounds were evaluated and the Lipinski's rules ve (RO5) of molecules were justied. All the selected compounds show good pharmacokinetics properties as well as maintenance of the RO5. The compound with good ADME properties has been further evaluated through the toxicity properties to measure the harmful effect on humans or animals. 75 Analysis of toxicity found no or less toxicity of the selected four compounds. Molecular dynamics simulation is used to conrm the stability of a protein in a complex with ligands. 75, 76 Also, it can determine the stability and rigidity of protein-ligand complexes in a specic articial environment like the body. 76 The RMSD values of the complex systems indicate the best stability of the compounds and RMSF values measure mean uctuation that determines the compactness of the protein-ligand complex. 77 The Ca atoms of the protein-ligand complexes were used to calculate the RMSD of the system that conrm low uctuation of the protein. The uctuation of the protein was also determined based on the RMSF value that also conrms low uctuation of the complex system indicated the stability of the compounds to the desired protein. The center of mass from the protein C and N terminals tests the stability of the protein structure and gives a broader understanding of protein folding characteristics for R g calculated. 78 The lower R g value means that high compactness and the larger value display the disassociation of the compounds from the protein and all the compounds show better R g value. 79 The larger SASA value indicates the less stable structure, whereas the lower value means the tightly contracted complex of water molecules and amino acid residues. 80, 81 The study found optimum R g and SASA values of the selected four compounds. The evaluation of selected four compounds based on different parameters supported diverse results, therefore the compound has been chosen for further assessment through various wet lab-based experimental methods. Drug design is becoming an essential, efficient, and external approach to identifying inhibitory compounds against a specic target protein. In this study, we describe the quick and successful identication of novel natural M pro inhibitors using a computer-aided drug design approach (CADD). The CADD include the molecular docking, ADMET, and MD simulation approaches that identied four natural compounds, CID: 70825, CID: 25247358, CID: 54685836, and CID: 1983 that can potentially inhibit the activity of M pro and result in blocking the replication of SARS-CoV-2 into the human host cell. This research received no external funding. MMR and FA designed the project; RA contributed to generate and analyze the data. RA, FA, RRI, MMR and SA wrote the manuscript; RRI and MEKT performed data analysis; RA, SA, MAH, FA, and MMR critically reviewed the manuscript. All authors read and approved the nal manuscript. The authors declare no conict of interest. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan Autoantibodies against type I IFNs in patients with lifethreatening COVID-19 Life-Threatening COVID-19: Defective Interferons Unleash Excessive Inammation, Med An overview of COVID-19 Challenges and Approaches of the Global Governance of Public Health Under COVID-19, Frontiers in Public Health Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection Novel corona virus (COVID-19); Global efforts and effective investigational medicines: A review Genotyping coronavirus SARS-CoV-2: methods and implications Predicting the recombination potential of severe acute respiratory syndrome coronavirus 2 and Middle East respiratory syndrome coronavirus Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV Identication of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analyses Spike protein recognizer receptor ACE2 targeted identication of potential natural antiviral drug candidates against SARS-CoV-2 Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping In silico studies of selected xanthophylls as potential candidates against SARS-CoV-2 targeting main protease (Mpro) and papain-like protease (PLpro) Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy Expression and Functions of SARS Coronavirus Replicative Proteins Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP Coronaviruses: an overview of their replication and pathogenesis Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods Antiviral potentials of medicinal plants Endophytes: A Treasure House of Bioactive Compounds of Medicinal Importance Drug discovery from medicinal plants Antioxidant Phytochemicals for the Prevention and Treatment of Chronic Diseases Phytochemicals Targeting VEGF and VEGF-Related Multifactors as Anticancer Therapy Reactive oxygen species: current knowledge and applications in cancer research and therapeutic A review on natural remedies used for the treatment of respiratory disorders Natural products for COVID-19 prevention and treatment regarding to previous coronavirus infections and novel studies Immunity: plants as effective mediators A Review on Herbal Remedies for Sexually Transmitted Infections (STIs) from Melghat Region of Maharashtra State, India Antioxidant potential fractionation from methanol extract of aerial parts of Ruellia prostrata poir (Acanthaceae) Quantitative and Fourier Transform Infrared Analysis of Saponins from Three Kenyan Ruellia Species: Ruellia prostrata, Ruellia linearibracteolata and Ruellia bignoniiora Ethnomedicinal plants used by traditional healers in Phatthalung Province, Peninsular Thailand BasuIndian medicinal plants International book distributors Phytochemical and pharmacological prole of Cassia tora Linn. -An Overview Extraction, characterization, and molecular weight determination of Senna tora (L.) seed polysaccharide Qualitative Analysis and Antimicrobial Activities on Leaves of Senna tora (L.) Roxb, 3 rd Myanmar Korea Biochemical Prole of Senna tora Linn Intraspecic directed deterrence by the mustard oil bomb in a desert plant Antifungal effect of Senna tora (L.) Roxb. Seed extract against Microsporum gypseum A study on trypsin, Aspergillus avus and Bacillus sp. protease inhibitory activity in Cassia tora (L.) syn Senna tora (L.) Roxb. seed extract Phenolic Compounds and Radical Scavenging Activity of Senna tora (L.) Roxb. Herbs Collected from Various Geographical Locations of India Formulation Development of Canine Antifungal Shampoo Containing Senna tora (L.) Roxb. Seed Extract Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review Pharmacophore-Based Virtual Screening, Quantum Mechanics Calculations, and Molecular Dynamics Simulation Approaches Identied Potential Natural Antiviral Drug Candidates against MERS-CoV S1-NTD Successful applications of computer aided drug discovery: moving drugs from concept to the clinic Role of computer-aided drug design in modern drug discovery Mikania cordata leaves extract promotes activity against pathogenic bacteria and anticancer activity in EAC cell-bearing swiss albino mice New Products Generated from the Transformations of Ferulic Acid Dilactone RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences Protein and ligand preparation: parameters, protocols, and inuence on virtual screening enrichments OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes Systems Pharmacology in Small Molecular Drug Discovery SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules Recent progress in drug delivery Addressing toxicity risk when designing and selecting compounds in early drug discovery ProTox-II: a webserver for the prediction of toxicity of chemicals Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters OPLS3e: Extending Force Field Coverage for Drug-Like Small Molecules Pharmacoinformatics and molecular dynamics simulation-based phytochemical screening of neem plant (Azadiractha indica) against human cancer by targeting MCM7 protein Pharmacophore-Based Virtual Screening, Quantum Mechanics Calculations, and Molecular Dynamics Simulation Approaches Identied Potential Natural Antiviral Drug Candidates against MERS-CoV S1-NTD Investigating the structure-activity relationship of marine natural polyketides as promising SARS-CoV-2 main protease inhibitors SARS-CoV-2 Comparison of Three Emerging Coronaviruses The 2020 race towards SARS-CoV-2 specic vaccines Anti-inammatory, antinociceptive and antidiarrhoeal activities of methanol and ethyl acetate extract of Hemigraphis alternata leaves in mice Natural products: an evolving role in future drug discovery Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants Biochemical and Computational Approach of Selected Phytocompounds from Tinospora crispa in the Management of COVID-19 Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy Lead-and drug-like compounds: the rule-of-ve revolution Overview on the Rule of Five Compounds Identied from Marine Mangrove Plant (Avicennia alba) as Potential Antiviral Drug Candidates Against WDSV, an In-Silico Approach Exploration of natural compounds with anti-SARS-CoV-2 activity via inhibition of SARS-CoV-2 M pro Screening of phytochemical compounds of Tinospora cordifolia for their inhibitory activity on SARS-CoV-2: an in silico study Screening of potential drug from Azadirachta Indica (Neem) extracts for SARS-CoV-2: An insight from molecular docking and MD-simulation studies Anti-SARS-CoV-2 activities of tanshinone IIA, carnosic acid, rosmarinic acid, salvianolic acid, baicalein, and glycyrrhetinic acid between computational and in vitro insights Computational discovery of plant-based inhibitors against human carbonic anhydrase IX and molecular dynamics simulation Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies The authors are grateful to the Laboratory of Computational Biology, Biological Solution Centre (BioSol Centre; http:// www.biosolcentre.org), Jashore 7408, Bangladesh for providing technical support.